-
1
-
-
34548512432
-
Filoviridae: Marburg and Ebola viruses
-
Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., Straus S.E., (eds), editors, Philadelphia (PA: Lippincott Williams & Wilkins
-
Sanchez A, Geisbert TW, Feldmann H. Filoviridae:Marburg and Ebola viruses. In:Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology fifth edition volume 1. Philadelphia (PA):Lippincott Williams & Wilkins; 2007, p. 1409-48.
-
(2007)
Fields virology fifth edition volume 1
, pp. 1409-1448
-
-
Sanchez, A.1
Geisbert, T.W.2
Feldmann, H.3
-
2
-
-
77953665114
-
Filoviruses are ancient and integrated into mammalian genomes
-
20569424
-
Taylor DJ, Leach RW, Bruenn J. Filoviruses are ancient and integrated into mammalian genomes. BMC Evol Biol 2010; 10:193; PMID:20569424; http://dx.doi.org/10.1186/1471-2148-10-193
-
(2010)
BMC Evol Biol
, vol.10
, pp. 193
-
-
Taylor, D.J.1
Leach, R.W.2
Bruenn, J.3
-
3
-
-
84944586743
-
Marburg and Ebola hemorrhagic fever (Filoviruses)
-
Bennet J.E., Dolin R., Blaser M.J., (eds), editors, Philadelphia (PA: Elsevier
-
Geisbert TW. Marburg and Ebola hemorrhagic fever (Filoviruses). In:Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases eighth edition. Philadelphia (PA):Elsevier; 2015, p 1995-9.
-
(2015)
Mandell, Douglas, and Bennett's principles and practice of infectious diseases eighth edition
, pp. 1995-1999
-
-
Geisbert, T.W.1
-
4
-
-
85015293662
-
-
Geneva (Switzerland: World Health Organization, Oct
-
World Health Organization. Ebola situation report-21 October 2015. Geneva (Switzerland):World Health Organization; 2015Oct21. http://apps.who.int/ebola/current-situation/ebola-situation-report-21-october-2015#main-content
-
Ebola situation report-21 October 2015
-
-
-
5
-
-
85050578622
-
Clinical development of Ebola vaccines
-
26668751
-
Sridhar S. Clinical development of Ebola vaccines. Ther Adv Vaccines 2015; 3(5–6):125-38; PMID:26668751; http://dx.doi.org/10.1177/2051013615611017
-
(2015)
Ther Adv Vaccines
, vol.3
, Issue.5-6
, pp. 125-138
-
-
Sridhar, S.1
-
6
-
-
84907263544
-
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
-
25194571
-
Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, Hensley L, Ammendola V, Abbate A, Grazioli F, et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nat Med 2014; 20(10):1126-9; PMID:25194571
-
(2014)
Nat Med
, vol.20
, Issue.10
, pp. 1126-1129
-
-
Stanley, D.A.1
Honko, A.N.2
Asiedu, C.3
Trefry, J.C.4
Lau-Kilby, A.W.5
Johnson, J.C.6
Hensley, L.7
Ammendola, V.8
Abbate, A.9
Grazioli, F.10
-
8
-
-
0019194453
-
Inactivated vaccine for Ebola virus efficacious in guineapig model
-
6108462
-
Lupton HW, Lambert RD, Bumgardner DL, Moe JB, Eddy GA. Inactivated vaccine for Ebola virus efficacious in guineapig model. Lancet 1980; 2(8207):1294-5; PMID:6108462; http://dx.doi.org/10.1016/S0140-6736(80)92352-1
-
(1980)
Lancet
, vol.2
, Issue.8207
, pp. 1294-1295
-
-
Lupton, H.W.1
Lambert, R.D.2
Bumgardner, D.L.3
Moe, J.B.4
Eddy, G.A.5
-
9
-
-
84934286956
-
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
-
25817373
-
Zhu FC, Hou LH, Li JX, Wu SP, Liu P, Zhang GR, Hu YM, Meng FY, Xu JJ, Tang R, et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China:preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet 2015; 385(9984):2272-9; PMID:25817373; http://dx.doi.org/10.1016/S0140-6736(15)60553-0
-
(2015)
Lancet
, vol.385
, Issue.9984
, pp. 2272-2279
-
-
Zhu, F.C.1
Hou, L.H.2
Li, J.X.3
Wu, S.P.4
Liu, P.5
Zhang, G.R.6
Hu, Y.M.7
Meng, F.Y.8
Xu, J.J.9
Tang, R.10
-
10
-
-
84940952795
-
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
-
26248676
-
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein:interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386(9996):857-66; PMID:26248676; http://dx.doi.org/10.1016/S0140-6736(15)61117-5
-
(2015)
Lancet
, vol.386
, Issue.9996
, pp. 857-866
-
-
Henao-Restrepo, A.M.1
Longini, I.M.2
Egger, M.3
Dean, N.E.4
Edmunds, W.J.5
Camacho, A.6
Carroll, M.W.7
Doumbia, M.8
Draguez, B.9
Duraffour, S.10
-
11
-
-
84942194673
-
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
-
26248510
-
Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, et al. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine:a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis 2015; 15(10):1156-66; PMID:26248510; http://dx.doi.org/10.1016/S1473-3099(15)00154-1
-
(2015)
Lancet Infect Dis
, vol.15
, Issue.10
, pp. 1156-1166
-
-
Huttner, A.1
Dayer, J.A.2
Yerly, S.3
Combescure, C.4
Auderset, F.5
Desmeules, J.6
Eickmann, M.7
Finckh, A.8
Goncalves, A.R.9
Hooper, J.W.10
-
12
-
-
84959184825
-
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
-
26546548
-
Tapia MD, Sow SO, Lyke KE, Haidara FC, Diallo F, Doumbia M, Traore A, Coulibaly F, Kodio M, Onwuchekwa U, et al. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo:a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2016; 16(1):31-42; PMID:26546548; http://dx.doi.org/10.1016/S1473-3099(15)00362-X
-
(2016)
Lancet Infect Dis
, vol.16
, Issue.1
, pp. 31-42
-
-
Tapia, M.D.1
Sow, S.O.2
Lyke, K.E.3
Haidara, F.C.4
Diallo, F.5
Doumbia, M.6
Traore, A.7
Coulibaly, F.8
Kodio, M.9
Onwuchekwa, U.10
-
13
-
-
84959245846
-
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
-
26725450
-
De Santis O, Audran R, Pothin E, Warpelin-Decrausaz L, Vallotton L, Wuerzner G, Cochet C, Estoppey D, Steiner-Monard V, Lonchampt S, et al. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults:a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. Lancet Infect Dis 2016; 16(3):311-20; PMID:26725450; http://dx.doi.org/10.1016/S1473-3099(15)00486-7
-
(2016)
Lancet Infect Dis
, vol.16
, Issue.3
, pp. 311-320
-
-
De Santis, O.1
Audran, R.2
Pothin, E.3
Warpelin-Decrausaz, L.4
Vallotton, L.5
Wuerzner, G.6
Cochet, C.7
Estoppey, D.8
Steiner-Monard, V.9
Lonchampt, S.10
-
14
-
-
85018193995
-
Chimpanzee adenovirus vector Ebola vaccine - preliminary report
-
25426834
-
Ledgerwood JE, DeZure AD, Stanley DA, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, et al. Chimpanzee adenovirus vector Ebola vaccine - preliminary report. N Engl J Med 2014; PMID:25426834; http://dx.doi.org/10.1056/NEJMoa1410863
-
(2014)
N Engl J Med
-
-
Ledgerwood, J.E.1
DeZure, A.D.2
Stanley, D.A.3
Novik, L.4
Enama, M.E.5
Berkowitz, N.M.6
Hu, Z.7
Joshi, G.8
Ploquin, A.9
Sitar, S.10
-
15
-
-
84939809433
-
Chimpanzee adenovirus vector Ebola vaccine–preliminary report
-
26287857
-
Ledgerwood JE, Sullivan NJ, Graham BS. Chimpanzee adenovirus vector Ebola vaccine–preliminary report. N Engl J Med 2015; 373(8):776; PMID:26287857
-
(2015)
N Engl J Med
, vol.373
, Issue.8
, pp. 776
-
-
Ledgerwood, J.E.1
Sullivan, N.J.2
Graham, B.S.3
-
16
-
-
85011081815
-
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine—Preliminary Report
-
25830322
-
Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Munoz P, et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine—Preliminary Report. N Engl J Med 2015; PMID:25830322; http://dx.doi.org/10.1056/NEJMoa1414216
-
(2015)
N Engl J Med
-
-
Regules, J.A.1
Beigel, J.H.2
Paolino, K.M.3
Voell, J.4
Castellano, A.R.5
Munoz, P.6
-
17
-
-
84964969174
-
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
-
25830326
-
Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, et al. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe. N Engl J Med 2016; 374(17):1647-60; PMID:25830326; http://dx.doi.org/10.1056/NEJMoa1502924
-
(2016)
N Engl J Med
, vol.374
, Issue.17
, pp. 1647-1660
-
-
Agnandji, S.T.1
Huttner, A.2
Zinser, M.E.3
Njuguna, P.4
Dahlke, C.5
Fernandes, J.F.6
Yerly, S.7
Dayer, J.A.8
Kraehling, V.9
Kasonta, R.10
-
18
-
-
84961050529
-
Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
-
Apr
-
Bengtsson KL, Song H, Stertman L, Liu Y, Flyer DC, Massare MJ, Xu RH, Zhou B, Lu H, Kwilas SA, Hahn TJ, Kpamegan E, Hooper J, Carrion R, Jr, Glenn G, Smith G. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine 2016 Apr 7; 34(16):1927-35; http://dx.doi.org/10.1016/j.vaccine.2016.02.033
-
(2016)
Vaccine
, vol.34
, Issue.16
, pp. 1927-1935
-
-
Bengtsson, K.L.1
Song, H.2
Stertman, L.3
Liu, Y.4
Flyer, D.C.5
Massare, M.J.6
Xu, R.H.7
Zhou, B.8
Lu, H.9
Kwilas, S.A.10
Hahn, T.J.11
Kpamegan, E.12
Hooper, J.13
Carrion, R.14
Glenn, G.15
Smith, G.16
-
19
-
-
78649703575
-
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
-
21034824
-
Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine 2010; 29(2):304-13; PMID:21034824; http://dx.doi.org/10.1016/j.vaccine.2010.10.037
-
(2010)
Vaccine
, vol.29
, Issue.2
, pp. 304-313
-
-
Ledgerwood, J.E.1
Costner, P.2
Desai, N.3
Holman, L.4
Enama, M.E.5
Yamshchikov, G.6
Mulangu, S.7
Hu, Z.8
Andrews, C.A.9
Sheets, R.A.10
-
21
-
-
77955511003
-
-
Atlanta (GA: Centers for Disease Control and Prevention, Jul
-
Centers for Disease Control and Prevention. Possible side-effects from vaccines. Atlanta (GA):Centers for Disease Control and Prevention; 20 Jul 2016. http://www.cdc.gov/vaccines/vac-gen/side-effects.htm
-
(2016)
Possible side-effects from vaccines
-
-
-
22
-
-
37649021448
-
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester
-
17853860
-
Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007; 2(9):2049-56; PMID:17853860; http://dx.doi.org/10.1038/nprot.2007.296
-
(2007)
Nat Protoc
, vol.2
, Issue.9
, pp. 2049-2056
-
-
Quah, B.J.1
Warren, H.S.2
Parish, C.R.3
-
23
-
-
84969513575
-
Powerful complex immunoadjuvant based on synergistic effect of combined TLR4 and NOD2 activation significantly enhances magnitude of humoral and cellular adaptive immune responses
-
27187797
-
Tukhvatulin AI, Dzharullaeva AS, Tukhvatulina NM, Shcheblyakov DV, Shmarov MM, Dolzhikova IV, Stanhope-Baker P, Naroditsky BS, Gudkov AV, Logunov DY, et al. Powerful complex immunoadjuvant based on synergistic effect of combined TLR4 and NOD2 activation significantly enhances magnitude of humoral and cellular adaptive immune responses. PLoS One 2016 11(5):e0155650; PMID:27187797; http://dx.doi.org/10.1371/journal.pone.0155650
-
(2016)
PLoS One
, vol.11
, Issue.5
, pp. 155650
-
-
Tukhvatulin, A.I.1
Dzharullaeva, A.S.2
Tukhvatulina, N.M.3
Shcheblyakov, D.V.4
Shmarov, M.M.5
Dolzhikova, I.V.6
Stanhope-Baker, P.7
Naroditsky, B.S.8
Gudkov, A.V.9
Logunov, D.Y.10
|